BTAI | BIOXCEL THERAPEUTICS INC

CUSIP: 09075P204

0 Funds Holding
0 Total Shares
$0 Total Value
$1.81
Price
$40M
Market Cap
P/E Ratio
-0.6
Forward P/E
$-9.29
EPS (TTM)
Dividend Yield
$36M
Cash
$103M
Total Debt
22M
Shares Out
$1.17
$8.08
52-Week Range

Institutional Ownership of BIOXCEL THERAPEUTICS INC

Fund / Manager Click to search
Shares Value % of Portfolio Cost Basis Est. Return
No funds currently hold this stock.

Trading Activity for BIOXCEL THERAPEUTICS INC

Fund / Manager Click to search
Action Change Shares After Value Price
No activity found for this stock.

Insider Trading for BIOXCEL THERAPEUTICS INC

6 Months Insider Sentiment
Buy $0 Sell $0
0 Buys
0 Sells
+0 Net
0 Grants
Date
Insider Click to search
Role Click to search
Type Shares Price Value
Dec 15, 2025 Frank Yocca Chief Scientific Officer EXERCISE 35
Dec 15, 2025 Vimal Mehta CEO and President EXERCISE 219
Dec 15, 2025 Richard I Steinhart Chief Financial Officer EXERCISE 35
Dec 15, 2025 Javier Rodriguez Chief Legal Officer, Senior Vice President and Corporate Secretary EXERCISE 35
Dec 14, 2025 Javier Rodriguez Chief Legal Officer, Senior Vice President and Corporate Secretary EXERCISE 33
Dec 14, 2025 Frank Yocca Chief Scientific Officer EXERCISE 33
Dec 14, 2025 Richard I Steinhart Chief Financial Officer EXERCISE 33
Dec 14, 2025 Vimal Mehta CEO and President EXERCISE 164
Oct 31, 2025 David J. Mack Director EXERCISE 1.7K
Sep 30, 2025 David J. Mack Director EXERCISE 1.7K
Sep 15, 2025 Javier Rodriguez Chief Legal Officer, Senior Vice President and Corporate Secretary EXERCISE 35
Sep 15, 2025 Richard I Steinhart Chief Financial Officer EXERCISE 35
Sep 15, 2025 Vimal Mehta CEO and President EXERCISE 219
Sep 15, 2025 Frank Yocca Chief Scientific Officer EXERCISE 35
Sep 14, 2025 Vimal Mehta CEO and President EXERCISE 163
Sep 14, 2025 Richard I Steinhart Chief Financial Officer EXERCISE 33
Sep 14, 2025 Javier Rodriguez Chief Legal Officer, Senior Vice President and Corporate Secretary EXERCISE 33
Sep 14, 2025 Frank Yocca Chief Scientific Officer EXERCISE 33
Aug 31, 2025 David J. Mack Director EXERCISE 1.7K